Dr. Siegel Discusses RT-Related AEs for Patients With Oropharyngeal Squamous Cell Carcinomas

Robert Siegel, MD
Published: Wednesday, Jul 05, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.

The standard of care for treating these patients is a combination of weekly low-dose chemotherapy with cisplatin and radiation therapy.

The short-term associated AE with radiation therapy can be difficulty eating. In the long-term, side effects include dry mouth and an altered sense of taste, which lead to implications such as gum disease and jaw bone decay.


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.

The standard of care for treating these patients is a combination of weekly low-dose chemotherapy with cisplatin and radiation therapy.

The short-term associated AE with radiation therapy can be difficulty eating. In the long-term, side effects include dry mouth and an altered sense of taste, which lead to implications such as gum disease and jaw bone decay.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations Across Lung, Head and Neck, and Bladder CancersApr 28, 20182.0
Publication Bottom Border
Border Publication
x